September 17, 2019 – Health Velocity Capital is excited to announce that Jenny Guyton has joined the firm as a Senior Associate and will be based in the firm’s Nashville office.
Jenny recently earned her MBA from The Wharton School at the University of Pennsylvania where she received a full, merit-based scholarship and graduated from the school’s Health Care Management program.
Prior to Wharton, Jenny led various acquisitions and new product development initiatives at The Advisory Board Company (NASDAQ: ABCO), a market-leading health care research, consulting, and technology company. While there, she was active in the acquisition of Clinovations, a highly successful EMR optimization consulting and services organization, and the development and launch of The Advisory Board’s self-service data analytics platform. She later spearheaded The Advisory Board’s strategic partnership program and led special projects for the company’s technology business, including a reorganization of the business. While at The Advisory Board Company, she worked closely with Health Velocity Capital Industry Advisory Board Member, David Felsenthal, who was then President of the organization.
Prior to The Advisory Board, Jenny worked in investment banking focused on mergers and acquisitions. She has also held positions at Town Hall Ventures, Flare Capital as a Flare Capital Scholar, Bridgewater Associates, and Google (NASDAQ: GOOG). Jenny received her BA in Ethics, Politics, and Economics from Yale University.
“I grew up with a chronic condition and was a frequent user of the US health care system as a child. Medically, my case was tougher than most. In every other way, my case was more fortunate. My father is one of ten siblings who are all physicians, and my mother selflessly served as what we would today call my care navigator,” says Jenny.
“As a patient, I experienced the clinical confusion and administrative frustration shared by millions of Americans each day. I also experienced medical innovation and care management that ultimately cured me. My experience showed me the opportunity – and imperative – we face to improve our system for patients.
I was drawn to Health Velocity Capital’s mission, of generating outstanding financial returns while contributing to a more sustainable and consumer-friendly health care system, and to their deep relationships and integration with their strategic investors who are working so hard to address these issues for patients.”
“We’re very pleased to have Jenny join our team,” according to Health Velocity Capital Partner Marty Felsenthal. “Through both her professional and personal experiences, she has shown a deep understanding of and commitment to our mission of improving our nation’s health care system, and we believe she will be a great addition to our investment activities as well as the symbiotic relationships we enjoy with our strategic investors.”
“As Health Velocity strives to be the preferred innovation partner of entrepreneurs and investors, Jenny’s Advisory Board Company experience working with technology utilized by our nation’s leading health systems will be valued by entrepreneurs and strategic investors alike,” added Partner Bruce Crosby. “Jenny is smart, motivated, and personable, and we’re excited to have her as part of the Health Velocity team.”
About Health Velocity Capital
Health Velocity Capital invests exclusively in innovative health care software and services companies. The firm’s partners have more than 50 collective years as investors, entrepreneurs, and executives helping to build innovative companies that created important new health care markets and that became market leaders, including successful companies such as Teladoc, Change Healthcare, US Renal Care, Aperio, Aspire Healthcare, The Advisory Board Company, Healthways (Tivity Health), MDLive, Infusion Express, Spero Health, OnShift, Vantage Oncology, D2Hawkeye, Compassus, iTriage, Contessa Health, Livongo, Circulation Health, and many others. In addition to investing on behalf of institutional investors, Health Velocity Capital invests on behalf of a number of our nation’s largest and most influential health care organizations and many of their top executives who collectively represent organizations that provide health insurance to more than 140 million Americans, operate almost 500 hospitals, provide pharmacy and PBM services to more than 75% of all Americans, and provide software and services to every major hospital in the United States. For more information, please visit www.healthvelocitycapital.com.